11.07.2015 Views

FINAL PROGRAM 6TH EDITION - EuroMediCom

FINAL PROGRAM 6TH EDITION - EuroMediCom

FINAL PROGRAM 6TH EDITION - EuroMediCom

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SKIN DEFECTS FILLING AND FACE REMODELLING IN THE SAME SESSION. ATLEAN ß TCP: A NEW AND INNOVATIVEAPPROACH TO FACE REJUVENATIONCOMBLEMENT DES IMPERFECTIONS DE LA PEAU ET REMODELAGE DU VISAGE EN UNE SEULE SÉANCE. ATLÉAN ß TCP :UNE APPROCHE NOUVELLE ET INNOVANTE DE RAJEUNISSEMENT DU VISAGERICCARDO FORTE(ITALY)AESTHETIC DERMATOLOGY & SURGERYBackground: Skin defects correction, like furrows, wrinkles, scars and facial re-modelling, represent a large part of the patient'sdemand in medical aesthetic treatements.Many new products and tecniques has been introduced during the last years, however, not many of the large number of injectablesintroduced during the last years can claim uniques and original features and performances. Here I am discussing a product claimingto fill and to biostimulate during the same session.Patients Material Methods: 40 patients has been treated for indications wich are the same of fillers and biostimulators: furrows andwrinkles, loose skin, photoaging and lipoatrophy. The ideal patient is up to middle aged, is asking for immediate but long termcorrection and wish a general skin quality improvement as well, in addition, does prefere not to go thru a long and expensive serie ofinjection sessions.The product, Atléan ß TCP, is available in pre-filled 1 ml syringes, is biocompatible, requires no preliminary test, is total reabsorbableand the experience showed that is easy and practical to inject.The tecniques are a combination of fillers and biostimulators, a 100% initial correction is suggested. Injection trauma is very limited noside effect has been recorded.Results: After one year of treatments and patients follow up, the results are very encouraging: high efficacy, cost effectivness andgood patients compliance has been recorded.The filling is immediate and is gradually decreasing along some weeks showing a good coordination with the effect of biostimulation,arising around 40 days after injection, acting strongly and which effect is completed few months later.Very good skin texture and skin brightness and an average of correction persistance of almost one year are basis for a very goodpatients compliance.Conclusions: An innovating, unique product, very often allowing for a creative and combined approach to face rejuvenation, moretime effective and cost effective than the usual current methods.THE ASSESSMENT OF RECOVERY TIME AND IMPACT OF DERMAL FILLER SECTION: THE E-ART STUDYEVALUATION DE LA DURÉE DE RÉCUPÉRATION ET PLACE DES PRODUITS DE COMBLEMENT : L'ÉTUDE D'E-ARTNOWELL SOLISH(CANADA)Background: The use of dermal fillers which are associated with recovery times of 4-7 days are not ideal in subjects with high societaldemands or in those who wish to preserve confidentiality regarding corrections and enhancement procedures without negativelyimpacting their daily activities. While clinical experience has provided many with first-hand experience to select products that can bestmatch a patient's expectations, little has been documented scientifically on the actual recovery time and the impact of filler selection.Methods: In order to assess the recovery time and overall impact of Glymatrix collagen filler (GCF), 30 subjects were recruited throughroutine clinic visits. Each was followed prospectively over a 7-14 day period with both in-office and diary documentation of aestheticcorrection satisfaction, recovery, and adverse events.Results: Recovery following cosmetic correction with GCF was rapid and met with a high degree of subject satisfaction. Adverseevents were minimal and of short duration. Conclusions: Cosmetic correction with GCF is associated with a short recovery time,allowing patients the ability to return to their normal daily routing quickly.REMODELLING THE FACE WITH VOLUMA TMREMODELAGE DU VISAGE AVEC VOLUMA TMBERNARD HERTZOG SONIA HANNOUN(FRANCE)This work started in 2005 in collaboration with Dr. Hannoun. We included approximately 80 patients in our sample population allthrough 2006. Results including 2007.We exclusively used " Voluma " TM , a new Hyaluronic acid product marketed by Laboratoire Cornéal, which has very interestingrheological characteristics, including increased elasticity (G') and stability of viscosity (G''), which leads to a G''/G' ratio close to 0,similar to a solid.We have created a new concept of injection, based on the reinjection of fat into the face (lipofilling). We replaced injection cannula withnew blunt-tipped needles which are finer and cause less trauma due to their spatula-shaped tip. The " needle " must always be orientedin the sub-cutaneous layer above the hypodermis and perfectly controlled retro-injections must be done (injecting the product whilewithdrawing the needle).2007: improving the injection with new finest needle !We have taken a new esthetic approach to the face. We have not only worked on increasing the volume caused by " Voluma " TM , wehave also used its viscoelastic properties to try to remodel the face.44

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!